Cargando…
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis (DVT) combined with a clinical pretest probability assessment. The intended use of the tests depends largely on th...
Autores principales: | Wauthier, Loris, Favresse, Julien, Hardy, Michaël, Douxfils, Jonathan, Le Gal, Grégoire, Roy, Pierre-Marie, van Es, Nick, Ay, Cihan, ten Cate, Hugo, Vander Borght, Thierry, Dupont, Michaël V., Lecompte, Thomas, Lippi, Giuseppe, Mullier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689068/ https://www.ncbi.nlm.nih.gov/pubmed/36428830 http://dx.doi.org/10.3390/diagnostics12112770 |
Ejemplares similares
-
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
por: Douxfils, Jonathan, et al.
Publicado: (2021) -
Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
por: Favresse, Julien, et al.
Publicado: (2022) -
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
por: Gillot, Constant, et al.
Publicado: (2021) -
Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
por: Douxfils, Jonathan, et al.
Publicado: (2021) -
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
por: Hardy, M., et al.
Publicado: (2020)